BriaCell Therapeutics Corp. Warrant (BCTXZ) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.08M | -7.97M | -7.7M | -8.13M | -7.16M | -5.92M | -6.96M | -4.06M | -4.99M | -7.4M | -7.5M | -11.12M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 1.2% | -34.58% | -10.78% | -100.22% | -43.66% | 20.01% | 7.23% | 63.47% | 4.93% | -85.57% | -116.23% | -234.24% |
| Net Income | -7.24M | -7.3M | -8.28M | -8.07M | -6.22M | -6.34M | -5.83M | -1.2M | 1.7M | -11.33M | 5.92M | -2.44M |
| Depreciation & Amortization | 33.01K | 26.66K | 26.66K | 26.59K | 26.66K | 26.66K | 26.66K | 71.5K | 3.79K | 3.82K | 3.76K | 3.85K |
| Stock-Based Compensation | 432.21K | 285.86K | 294.69K | 0 | 224.81K | 285.09K | 266.97K | 0 | 0 | 500.15K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -400.42K | -60.3K | 24.54K | -510.96K | -113.09K | -764.26K | 688.16K | -4.23M | -10.38M | 1.59M | -13.59M | -4.67M |
| Working Capital Changes | 95.69K | -922.62K | 227.65K | 423.06K | -1.08M | 870.11K | -2.11M | 1.3M | 3.69M | 1.84M | 177.76K | -4.01M |
| Change in Receivables | -319.11K | -790.4K | 887.86K | -3.17K | 90.27K | 277.91K | 364.94K | -721.11K | 14.77K | -12 | -2.5K | -4.02K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 | 0 |
| Change in Payables | 0 | -249.27K | -1.15M | 0 | -1.72M | 769.27K | -2.94M | 0 | 0 | 3.28M | -680.02K | 0 |
| Cash from Investing | -16.3M | 7.28M | -75K | -7.48M | -105K | -75K | -75K | -448.65K | -222.47K | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -447.44K | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | -95K | -90K | -75K | 0 | -105K | -75K | -75K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -16.2M | 7.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -108.65K | 27.87M | 0 | 13.56M | 14.71M | 5.22M | 11.96M | 4.33M | 0 | 0 | 0 | 4.06M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -108.65K | 27.87M | 0 | 13.56M | 14.71M | 4.69M | 11.67M | 4.33M | 0 | 0 | 0 | 4.06M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -111 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 527.76K | 293.25K | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -22.9M | 27.19M | -7.78M | -1.96M | 7.45M | -778.61K | 4.93M | -68.15K | -5.16M | -7.4M | -6.56M | -7.74M |
| Free Cash Flow | -7.21M | -7.97M | -7.7M | -8.13M | -7.16M | -5.92M | -6.96M | -4.51M | -4.99M | -7.4M | -7.5M | -11.12M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -0.6% | -34.58% | -10.78% | -80.35% | -43.66% | 20.01% | 7.23% | 59.44% | 4.93% | -85.57% | -116.23% | -234.24% |
| FCF per Share | -0.99 | -2.84 | -4.09 | -4.32 | -19.17 | -21.93 | -39.16 | -37.51 | -46.80 | -69.47 | -67.44 | -104.33 |
| FCF Conversion (FCF/Net Income) | 0.99x | 1.10x | 0.94x | 1.01x | 1.17x | 0.94x | 1.20x | 3.39x | -2.93x | 0.65x | -1.27x | 4.55x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |